APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,494 | +366.6% | 4,850 | +1017.5% | 0.26% | +477.8% |
| Q2 2023 | $39,537 | +10.2% | 434 | -20.2% | 0.04% | +7.1% |
| Q1 2023 | $35,882 | -82.8% | 544 | -86.5% | 0.04% | -83.5% |
| Q4 2022 | $209,115 | +14.9% | 4,044 | +52.1% | 0.26% | +28.8% |
| Q3 2022 | $182,000 | +142.7% | 2,659 | +60.8% | 0.20% | +160.5% |
| Q2 2022 | $75,000 | -55.4% | 1,654 | -49.9% | 0.08% | -25.5% |
| Q1 2022 | $168,000 | -72.4% | 3,299 | -74.3% | 0.10% | -62.4% |
| Q4 2021 | $608,000 | +14.7% | 12,855 | -20.1% | 0.27% | +40.4% |
| Q3 2021 | $530,000 | -36.5% | 16,088 | +21.9% | 0.19% | -29.8% |
| Q2 2021 | $834,000 | +94.4% | 13,200 | +32.0% | 0.28% | +65.7% |
| Q1 2021 | $429,000 | -25.0% | 10,000 | 0.0% | 0.17% | -61.7% |
| Q4 2020 | $572,000 | – | 10,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |